Calbindin S100A16 Promotes Renal Cell Carcinoma Progression and Angiogenesis via the VEGF/VEGFR2 Signaling Pathway

Figure 1

Elevated S100A16 expression in RCC. (a) S100A16 expression in renal clear cell carcinoma. (b) Expression of S100A16 in RCC unpaired tissues (tumor 539-normal 72). (c) S100A16 expression in paired RCC and normal tissue (tumor 72 -normal 72). (d) S100A16 ROC analysis demonstrated ability to distinguish between tumor and normal tissues. p < 0.05, p < 0.01, p < 0.001. Relationship between S100A16 in TCGA database and clinical data of RCC.

(a)

(b)

(c)

(d)